| Ident. | Authors (with country if any) | Title |
|---|
| 000396 (2021) |
Fanny Onodi [France] ; Lucie Bonnet-Madin [France] ; Laurent Meertens [France] ; Léa Karpf [France] ; Justine Poirot [France] ; Shen-Ying Zhang [France, États-Unis] ; Capucine Picard [France] ; Anne Puel [France, États-Unis] ; Emmanuelle Jouanguy [France, États-Unis] ; Qian Zhang [États-Unis] ; Jérôme Le Goff [France] ; Jean-Michel Molina [France] ; Constance Delaugerre [France] ; Jean-Laurent Casanova [France, États-Unis] ; Ali Amara [France] ; Vassili Soumelis [France] | SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4. |
| 000429 (2021) |
Simone Sukhdeo [États-Unis] ; Emily Negroponte [États-Unis] ; Hariprem Rajasekhar [États-Unis] ; Sunanda Gaur [États-Unis] ; Daniel B. Horton [États-Unis] ; Amisha Malhotra [États-Unis] ; L Nandini Moorthy [États-Unis] | Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus. |
| 000726 (2021) |
Miroslaw Kiedrowski [Pologne] ; Przemyslaw Kapala [Pologne] ; Marlena Kiedrowska [Pologne] ; Anna Skoczynska [Pologne] ; Aleksandra Czerw [Pologne] ; Andrzej Deptała [Pologne] | Can chloroquine/hydroxychloroquine prove efficient in cancer cachexia? A hypothesis in the era of COVID-19. |
| 000898 (2020) |
Laura M. Sly ; Peter Braun ; Barry G. Woodcock | COVID-19: Cytokine storm modulation/blockade with oral polyvalent immunoglobulins (PVIG, KMP01D): A potential and safe therapeutic agent (Primum nil nocere). |
| 000911 (2021) |
Zhi-Yuan Pan [République populaire de Chine] ; Yu-Xiao Chang [République populaire de Chine] ; Ni Han [République populaire de Chine] ; Feng-Yi Hou [République populaire de Chine] ; B J Yang Lee [République populaire de Chine] ; Fa-Chao Zhi [République populaire de Chine] ; Rui-Fu Yang [République populaire de Chine] ; Yu-Jing Bi [République populaire de Chine] | Short-term high-dose gavage of hydroxychloroquine changes gut microbiota but not the intestinal integrity and immunological responses in mice. |
| 000964 (2020) |
Kyle Rosenke [États-Unis] ; Michael A. Jarvis [États-Unis, Royaume-Uni] ; Friederike Feldmann ; Benjamin Schwarz [États-Unis] ; Atsushi Okumura [États-Unis] ; Jamie Lovaglio ; Greg Saturday ; Patrick W. Hanley ; Kimberly Meade-White [États-Unis] ; Brandi N. Williamson [États-Unis] ; Frederick Hansen [États-Unis] ; Lizette Perez-Perez [États-Unis] ; Shanna Leventhal [États-Unis] ; Tsing-Lee Tang-Huau [États-Unis] ; Julie Callison [États-Unis] ; Elaine Haddock [États-Unis] ; Kaitlin A. Stromberg [États-Unis] ; Dana Scott ; Graham Sewell [Royaume-Uni] ; Catharine M. Bosio [États-Unis] ; David Hawman [États-Unis] ; Emmie De Wit [États-Unis] ; Heinz Feldmann [États-Unis] | Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models. |
| 000A19 (2020) |
Fabrizio Cantini [Italie] ; Delia Goletti [Italie] ; Linda Petrone [Italie] ; Saied Najafi Fard [Italie] ; Laura Niccoli [Italie] ; Rosario Foti [Italie] | Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review. |
| 000A27 (2020) |
Seidu A. Richard ; Sylvanus Kampo [Ghana] ; Maite Esquijarosa Hechavarria [Ghana] ; Marian Sackey ; Alexis D B. Buunaaim [Ghana] ; Eugene Dogkotenge Kuugbee [Ghana] ; Thomas Winsum Anabah [Ghana] | Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine. |
| 000B17 (2020) |
Burak Pamukçu | Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2. |
| 000C59 (2020) |
Daniel R. Burrage [Royaume-Uni] ; Soraya Koushesh [Royaume-Uni] ; Nidhi Sofat [Royaume-Uni] | Immunomodulatory Drugs in the Management of SARS-CoV-2. |
| 000C68 (2020) |
Mahdieh Razmi [Iran] ; Farideh Hashemi [Iran] ; Elmira Gheytanchi [Iran] ; Masoumeh Dehghan Manshadi [Iran] ; Roya Ghods [Iran] ; Zahra Madjd [Iran] | Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review. |
| 000C88 (2021) |
Wang-Da Liu [Taïwan] ; Sui-Yuan Chang [Taïwan] ; Ting-Yuan Lan [Taïwan] ; Yen-Chun Lin [Taïwan] ; Jui-Hung Kao [Taïwan] ; Chun-Hua Liao [Taïwan] ; Ming-Jui Tsai [Taïwan] ; Po-Hsien Kuo [Taïwan] ; Yu-Shan Huang [Taïwan] ; Jann-Tay Wang [Taïwan] ; Wang-Huei Sheng [Taïwan] ; Song-Chou Hsieh [Taïwan] ; Bor-Luen Chiang [Taïwan] ; Yee-Chun Chen [Taïwan] ; Shan-Chwen Chang [Taïwan] | Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics. |
| 000F09 (2020) |
Huiying Xue [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Pan Luo [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine] | Hydroxychloroquine treatment in COVID-19: A descriptive observational analysis of 30 cases from a single center in Wuhan, China. |
| 001078 (2020) |
Pauline Maisonnasse [France] ; Jérémie Guedj [France] ; Vanessa Contreras [France] ; Sylvie Behillil [France] ; Caroline Solas [France] ; Romain Marlin [France] ; Thibaut Naninck [France] ; Andres Pizzorno [France] ; Julien Lemaitre [France] ; Antonio Gonçalves [France] ; Nidhal Kahlaoui [France] ; Olivier Terrier [France] ; Raphael Ho Tsong Fang [France] ; Vincent Enouf [France] ; Nathalie Dereuddre-Bosquet [France] ; Angela Brisebarre [France] ; Franck Touret [France] ; Catherine Chapon [France] ; Bruno Hoen [France] ; Bruno Lina [France] ; Manuel Rosa Calatrava [France] ; Sylvie Van Der Werf [France] ; Xavier De Lamballerie [France] ; Roger Le Grand [France] | Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. |
| 001093 (2020) |
Mohammad Sultan Khuroo [Inde] | Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal. |
| 001153 (2020) |
Shifaa M. Abdin [Émirats arabes unis] ; Sara M. Elgendy [Émirats arabes unis] ; Shatha K. Alyammahi [Émirats arabes unis] ; Dima W. Alhamad [Émirats arabes unis] ; Hany A. Omar [Égypte] | Tackling the cytokine storm in COVID-19, challenges and hopes. |
| 001199 (2020) |
Xing Li [République populaire de Chine] ; Ying Wang [République populaire de Chine] ; Patrizia Agostinis [Belgique] ; Arnold Rabson [États-Unis] ; Gerry Melino [Italie] ; Ernesto Carafoli [Italie] ; Yufang Shi [République populaire de Chine] ; Erwei Sun [République populaire de Chine] | Is hydroxychloroquine beneficial for COVID-19 patients? |
| 001221 (2020) |
Xuesong Chen [États-Unis] ; Jonathan D. Geiger [États-Unis] | Janus sword actions of chloroquine and hydroxychloroquine against COVID-19. |
| 001223 (2020) |
Teodoro J. Oscanoa [Pérou] ; Roman Romero-Ortuno [Irlande (pays)] ; Alfonso Carvajal [Espagne] ; Andrea Savarino [Italie] | A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus? |
| 001340 (2020) |
Brian Lipworth [Royaume-Uni] ; Chris Ruiwen Kuo [Royaume-Uni] ; Rory Chan [Royaume-Uni] | Emerging pharmacotherapy for COVID-19. |
| 001380 (2020) |
Chitra Bamba [Inde] ; Surinder P. Singh [Inde] ; Sangeeta Choudhury [Inde] | Can mesenchymal stem cell therapy be the interim management of COVID-19? |
